Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery

Related Experiment Videos

Jun Wang1, Ah Siew Sim, Xing Li Wang

  • 1Department of Cardiovascular Medicine, University of New South Wales, Prince of Wales Hospital, Sydney, Australia.

Atherosclerosis
|September 11, 2007
PubMed

Insights

Mild renal impairment, indicated by elevated cystatin C, is linked to coronary artery disease (CAD) occurrence and severity. This finding suggests cystatin C may be an early CAD marker and involved in atherogenesis.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Renal failure significantly elevates coronary risk.
  • Mild renal impairment is often underestimated as a cardiovascular risk factor.

Purpose of the Study:

  • To investigate the association between mild renal impairment and coronary artery disease (CAD).
  • To identify early markers for CAD in patients with reduced kidney function.

Main Methods:

  • Assessed 408 patients (age <=75) with normal or obstructed coronary arteries and estimated glomerular filtration rate (eGFR) >45 mL/min/1.73 m(2).
  • Measured plasma cystatin C, creatinine, eGFR, lipid profile, C-reactive protein (CRP), homocysteine, asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA).
  • Utilized univariate ANOVA and multivariate analysis to determine associations between renal function indices and CAD severity.

Main Results:

  • CAD severity correlated significantly with all renal function indices: increased cystatin C and creatinine, and decreased eGFR.
  • Elevated cystatin C was associated with higher levels of ADMA, SDMA, CRP, and homocysteine.
  • Multivariate analysis showed increased cystatin C as a stronger predictor of CAD occurrence and severity than other renal measures.

Conclusions:

  • Mild renal impairment, identified by elevated cystatin C, is independently associated with CAD occurrence and severity.
  • Mild renal impairment increases plasma levels of homocysteine, ADMA, and SDMA.
  • Cystatin C may serve as an early marker for CAD and play a role in atherogenesis.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...